Literature DB >> 7662701

Cathepsin D-like aspartyl protease activity mediates the degradation of tissue-type plasminogen activator/plasminogen activator inhibitor-1 complexes in human monocytes.

D I Simon1, H Xu, D E Vaughan.   

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is the most important inhibitor of tissue-type plasminogen activator (t-PA) in plasma and plays a major role in the regulation of fibrinolysis. Plasma t-PA/PAI-1 complexes are cleared via a receptor-dependent mechanism in hepatocytes, while the fate of complexes formed in the extracellular matrix and in thrombi is less well understood. In this study, the degradation of t-PA/PAI-1 complexes by monocytes was examined. THP-1 monocytoid cells and freshly isolated human monocytes internalize and degrade [125I]t-PA/PAI-1 complexes at rates of 11.4 +/- 5.9 (mean +/- S.D.) and 44.6 +/- 6.3 ng/10(6) cells/h, respectively. Degradation is blocked by receptor-associated protein (RAP), indicating a member of the low density lipoprotein (LDL) receptor family is involved in the uptake/degradation of t-PA/PAI-1 complexes by monocytes. Degradation of t-PA/PAI-1 complexes is also inhibited by chloroquine and by pepstatin A, suggesting that a lysosomal aspartyl protease is likely involved. SDS-PAGE and Western blotting demonstrated that the purified lysosomal aspartyl protease, cathepsin D, is capable of digesting t-PA (t1/2 15 min), active PAI-1 (t1/2 2 h), and t-PA/PAI-1 complex (t1/2 30 min). Cathepsin D sequentially cleaves PAI-1 after hydrophobic amino acids, yielding lower molecular weight fragments. PAI-1 conformation influences the degradative efficiency of cathepsin D, with vitronectin-bound PAI-1 and latent PAI-1 exhibiting resistance to proteolysis and > 10-fold prolongation in t1/2. These data provide evidence that t-PA/PAI-1 complexes are internalized by human monocytes via a member of the low density lipoprotein (LDL) receptor family, and identifies cathepsin D-like aspartyl protease activity as largely responsible for the degradation of these complexes. Furthermore, vitronectin-bound PAI-1 and latent PAI-1 are relatively resistant to degradation by cathepsin D, which may be of importance in complex physiological environments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662701     DOI: 10.1016/0167-4889(95)00063-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

Authors:  D A Waltz; L R Natkin; R M Fujita; Y Wei; H A Chapman
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.

Authors:  Fatma H Al-Awadhi; Brian K Law; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2017-10-31       Impact factor: 4.050

3.  Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

4.  Vitronectin and Its Interaction with PAI-1 Suggests a Functional Link to Vascular Changes in AMD Pathobiology.

Authors:  Fabiola Biasella; Tobias Strunz; Christina Kiel; Bernhard H F Weber; Ulrike Friedrich
Journal:  Cells       Date:  2022-05-27       Impact factor: 7.666

5.  tPA receptors and the fibrinolytic response in multiple sclerosis lesions.

Authors:  Djordje Gveric; Blanca M Herrera; M Louise Cuzner
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

6.  Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.

Authors:  P Protiva; I Sordat; P Chaubert; E Saraga; C Trân-Thang; B Sordat; A L Blum; G Dorta
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

Review 7.  Specific functions of lysosomal proteases in endocytic and autophagic pathways.

Authors:  Sabrina Müller; Julia Dennemärker; Thomas Reinheckel
Journal:  Biochim Biophys Acta       Date:  2011-07-13

8.  Embolizing Massive Right Atrial Thrombus in a HIV-Infected Patient.

Authors:  Piruthiviraj Natarajan; Fowrooz Joolhar; Sudhagar Thangarasu; Ayham Aboeed; Theingi Tiffany Win; Everardo Cobos
Journal:  J Investig Med High Impact Case Rep       Date:  2018-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.